Description

Daveris (travoprost) Eye Drops 40 mcg/ml. 2.5 ml Vial

Ingredients

Active ingredient: Travoprost 40 mcg/ml.

Dosage

Dosage: The usual dose is 1 drop in the affected eye(s) once daily in the evening.

Indications

Indications: Daveris eye drops are indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

Contraindications

Contraindications: Do not use Daveris eye drops if you are allergic to travoprost or any other ingredients in the formulation.

Directions

Directions: Wash hands before use. Tilt your head back, pull down the lower eyelid, and instill the prescribed number of drops. Close your eye for 1 to 2 minutes.

Scientific Evidence

Daveris eye drops containing travoprost have shown significant efficacy in reducing intraocular pressure in patients with glaucoma. Studies have demonstrated that travoprost, a prostaglandin analog, effectively increases uveoscleral outflow, thereby reducing intraocular pressure and preserving visual function.

Additional Information

It is important to adhere to the prescribed dosage and frequency of Daveris eye drops to achieve optimal therapeutic outcomes. Contact your healthcare provider if you experience any adverse reactions or have concerns about the medication.

Pharmacological Effects: Travoprost, the active ingredient in Daveris eye drops, works by increasing the outflow of aqueous humor from the eye, thus lowering intraocular pressure. This mechanism of action helps in the management of conditions like glaucoma.

Clinical Trials: Clinical trials have demonstrated the efficacy of travoprost in reducing intraocular pressure and its role in the treatment of glaucoma. A study by Alm et al. (2005) showed that travoprost was well-tolerated and effective in lowering intraocular pressure over a 12-month period.